UBE2V1通过与HIF-1α形成正反循环,促进肝细胞癌的进展
Zibo Yuan1,2,3, Sipin Hu3,4, Qingwei Zhu3,5
1General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
一项新的研究揭示了一个积极的反循环,涉及缺氧诱导因子-1α (HIF-1α) 和全方位合酶E2变异1 (UBE2V1),驱动肝细胞癌 (HCC) 的进展. UBE2V1作为HCC的治疗标和预后生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 具有缺氧微环境的特征,促进瘤的攻击性和不良结果.
- 缺氧驱动HCC进展的确切机制尚未完全理解.
研究的目的:
- 在HCC中识别新的低氧反应基因.
- 阐明HCC进展中缺氧的调节机制.
- 评估UBE2V1作为HCC的潜在治疗标和预后生物标志物.
主要方法:
- 通过促进体分析识别低氧反应基因.
- 评估UBE2V1在HCC组织中的表达和与临床结果的相关性.
- 在体外测试以确定UBE2V1在HCC细胞增殖和迁移中的作用.
- 研究UBE2V1,HIF-1α和VHL蛋白之间的分子相互作用.
- 使用基因淘汰和药物抑制的体内研究.
主要成果:
- UBE2V1是一种新型低氧反应基因,由HIF-1α转录激活.
- 在HCC中UBE2V1过度表达与晚期和不良预后相关.
- UBE2V1促进HCC细胞的增殖和迁移.
- UBE2V1破坏了VHL功能,稳定了HIF-1α并维持了缺氧反应.
- 抑制UBE2V1或抑制HIF-1α可以抑制HCC的瘤发生和转移.
结论:
- HIF-1α 和 UBE2V1 之间的正反循环维持了低氧微环境,推动了 HCC 的进展.
- UBE2V1是HCC瘤发生和转移的关键调节者.
- UBE2V1代表了一个有前途的预后生物标志物和HCC的治疗目标.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
相关概念视频
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
Mechanisms of Retrovirus-induced Cancers
Cell Specific Gene Expression
